Stock CLS B CLINICAL LASERTHERMIA SYSTEMS AB
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Clinical Laserthermia Systems AB

Equities

CLS B

SE0022049920

Delayed Nasdaq Stockholm
Other stock markets
 10:41:37 28/05/2024 BST 		5-day change 1st Jan Change
21.74 SEK -3.76% Intraday chart for Clinical Laserthermia Systems AB +35.84% -21.25%
05-14 Clinical Laserthermia Systems AB Enters into an Exclusive Distribution Agreement with MTEC Company CI
04-30 Clinical Laserthermia Notes US FDA Clearance for ClearPoint's Prism Bone Anchor Accessory MT

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company has insufficient levels of profitability.
  • The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
  • Based on current prices, the company has particularly high valuation levels.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • Over the past four months, analysts' average price target has been revised downwards significantly.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
CLINICAL LASERTHERMIA SYSTEMS AB Stock Clinical Laserthermia Systems AB
-21.25% 16.71M -
EL.EN. S.P.A. Stock EL.En. S.p.A.
+6.67% 899M
B+
SISRAM MEDICAL LTD Stock Sisram Medical Ltd
-26.24% 234M -
LASEROPTEK CO., LTD. Stock Laseroptek Co., Ltd.
-38.71% 71.85M - -
MODULIGHT OYJ Stock Modulight Oyj
+17.89% 68.59M -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. CLS B Stock
  4. Ratings Clinical Laserthermia Systems AB